Curriculum Vitae
Cheryl A. Kollin, NMD

GRADUATE & POSTGRADUATE EDUCATION
• Southwest College of Naturopathic Medicine, Tempe, AZ (2/09- 12/12)
Doctor of Naturopathy (NMD)
• University of Bridgeport, Bridgeport, CT (9/05- 5/07)
M.S. Nutrition
• California State University Dominquez Hills, Carson, CA (1992-1993)

PROFESSIONAL SCHOOL EDUCATION
• St. Mary Medical Center, School of Medical Technology, Long Beach, CA (1993-
1994)

UNDERGRADUATE EDUCATION
• Oral Roberts University, Tulsa, OK (1988-1992)
B.S. Biology (major), Chemistry and Spanish (minors)
Molecular Biology Research and Paper: Comparison of the Cofactor Requirements
for Iron Reductase Secreted by Listeria monocytogenes and for Iron Reductase
Produced by Cloned Listeria DNA.

LICENSURE
• Naturopathic Medical License, NMD, Arizona State (AZ 13-1361)
• Clinical Laboratory Scientist, CLS, California State License (MTA36232)

CERTIFICATION BOARDS
• Certified Clinical Nutritionist (CCN), #4037 (2007-present)
• MT (ASCP) Certified #193720 (1994-present)
• NCA Certified (1994)

EMPLOYMENT HISTORY
• October 2014 to Present, Naturopathic Medical Doctors of Arizona, Tempe, AZ,
Physician
• April 2013 to October 2014, Naturopathic Medical Doctors of Arizona, Tempe, AZ,
Independent Physician Contractor
• March 2008 to August 2010, American Nutrition Association, Chicago, IL, Director
of Research, Online Division
• September 2001 to January 2009, Rational Therapeutics, Inc., Long Beach, CA,
Senior Scientist, CLS I/II
• January 1993- September 2001, St. Mary Medical Center, Long Beach, CA, Medical
Technologist I/II.

SMALL BUSINESS
• Kollin Medical (2014 to Present)
o Az Oncology Rehab
• Cheryl K Nutrition (2007 to 2008)

PROFESSIONAL MEMBERSHIPS
• Sigma Xi, Scientific Research Society, associate member (1992 to 2006).
• American Society of Clinical Pathology, ASCP, associate member (1994 to present)
• International and American Association of Clinical Nutritionists, IAACN (2007 to
present)
• American Association of Naturopathic Physicians, AANP (2009 to present)
• Arizona Naturopathic Medical Association (AzNMA), (2010 to present)
• American College for the Advancement of Medicine (ACAM), (2012 to present)

PUBLICATIONS
Manuscripts:
• Brewer CA, Evans SS, Kollin CA, Sommers BL, Su YZ, Nagourney RA. Comparison
of 1st Line Treatment Options In Epithelial Ovarian Cancer: Ex Vivo Analysis in
Human Tumor Primary Culture Micro-spheroids. (pending)

Abstracts:
• Nagourney RA, Kollin CA, Sommers B, Su YZ, Francisco F, Evans SS. Bortezomib
combinations in ovarian cancer: Ex vivo analysis of activity and synergy in human
tumor primary culture spheroids. (2158) Amer Assoc for Canc Res, 2006. (abst)
• Nagourney RA, Sommers BL, Evans SS, Kollin C, Su YZ, Evans T, Islas J, Kakkis J,
Tabar L. Casting-type calcification breast cancer: Assessment of response to
cytotoxic insult in human tumor primary culture spheroids. (680) Amer Soc of
Clin Oncol 24, 2005 (abst)
• Kollin C, Su YZ, Evans SS, Nagourney RA. The effects of EGFr modulation by
Cetuximab & Gefitinib in human tumor primary culture microspheroids. (2170)
Amer Assoc of Canc Res 46, 2005 (abst)
• Nagourney RA, Kollin C, Su YZ, Evans SS. Geldanamycin & 17-allylamino-17-
demethoxygeldanamycin alone and in combination with cytotoxic drugs in human
tumor primary cultures. (1713) Amer Assoc of Canc Res 46, 2005 (abst)
• Evans S, Brewer C, Kollin C, Su YZ, Nagourney RA. The role of targeted therapies
in ovarian cancer: Examination of drug activity in human primary culture
spheroids. (5324) Amer Assoc of Canc Res 46, 2005 (abst)
• Nagourney RA, Su, YZ, Horlick D, Chow C, Kollin C, Evans SS. Bortezomib (PS-341)
alone and in combination with cytotoxic drugs: Ex vivo analysis in human tumor
primary cultures. (3690) Amer Assoc of Canc Res 45, 2004 (abst)
• Evans SS, Brewer C, Su YZ, Yeung C, Chow C, Horlick D, Kollin C, Nagourney RA.
Gemcitabine/Antifol combinations in human tumor primary cultures: Potential
role in gynecologic malignancies. (4446) Amer Assoc of Canc Res 45, 2004 (abst)
• Nagourney RA, Chow C, Kollin C, et al. Effect of gefitinib (Iressa, ZD 1839) in
human tumor primary cultures: Possible insights into drug actions. (3801) Amer
Assoc of Canc Res 44, 870, 2003 (abst)
• Kollin CA, Evans SS, Su, Y-Z Su, et al. A direct comparison of paclitaxel and
docetaxel activities in human tumors. (655) Proc Amer Soc Clin Oncol 22, 163,
2003 (abstr)
• Su YZ, Kollin C, Horlick D et al. Activity of ZD1839 (Iressa) alone and combined
with cytotoxic drugs in human tumor primary cultures. (3902) Amer Assoc for
Canc Res. 2002. (abst)
• Su YZ, Spall D, Trail MA, Kollin C et al. BEC, a mixture of solasodine glycosides
reveals cytotoxic activity in human tumor primary culture specimens: Pre-clinical
and early clinical observations. (1070). Proc Amer Assoc Canc Res 43:214, 2002
(abstr)
• Nagourney RA, Su YZ, Chow C, Kollin C et al. Arsenic Trioxide (Trisenox) single
agent and combination activity in human lung, colon, breast, and ovarian primary
cultures. ASCO Vol 21, 2002, #2189.
CONTINUING EDUCATION
• Understanding the Clinical Uses of Blood Gases and Electrolytes. AACC 1994. 15
hours
• Cardiac Markers for Diagnosing and Monitoring Heart Disease. AACC 1995. 15
hours
• Transfusion Medicine. ASCP 1994 & 1995 Check Sample Program. 1996. 12 hours
• Laboratory Identification of Blood Parasites. CACMLE 1997. 15 hours
• Clinical Lab Mycology. CACMLE 1998. 15 hours
• Transfusion Medicine. ASCP 1998 & 1999 Check Sample Program. 1999. 16 hours.
• A Review of Routine Hematology Laboratory Procedures. CACMLE 2000. 15 hours
• Transfusion Medicine. ASCP 1999 & 2000 Check Sample Program 2001. 16 hours
• Harper’s Biochemistry, Section A. Anderson Continuing Education 2002. 12 hours
• Harper’s Biochemistry, Section B. Anderson Continuing Education 2003. 12 hours
• Harper’s Biochemistry, Section C. Anderson Continuing Education 2004. 12 hours
• Understanding & Evaluating Common Laboratory Tests, Section A. Anderson CE
2005. 12 hours
• Clinical Biochemistry. Univ. of Bridgeport, Nutrition program. 2006. 3 units = 45
hours.
• Epidemiology and Statistics. Univ. of Bridgeport, Nutrition program. 2007. 3 units
= 45 hours.
• Managing Men’s & Women’s Health. Metagenics Educational Programs, Presented
by Kristi Hughes, ND. Oct. 2005. 6 hours.
• Understanding The Origins & Applying Advanced Nutritional Strategies For
Autoimmune Disease. Metagenics Educational Programs, Presented by Jeffrey S.
Bland, PhD. Feb. 18, 2006. 6 hours
• Obesity-Related Health Problems: New Understanding & New Solutions.
Metagenics Educational Programs, Presented by Robert Rakowski, DC, CCN. Feb.
19, 2006. 6 hours
• Restoring Patient Health through Functional Endocrinology. Metagenics
Educational Programs, Presented by Robert Rakowski, DC, CCN. 2006. 6 hours
• Managing the Multiple Causes of Chronic Inflammation. Metagenics Educational
Programs, Presented by Jacob Kornberg, MD. Oct 2006. 6 hours
• The Neurobiology of Mood & Cognitive Disorders, Metagenics Educational
Programs, Presented by Jay Lombard, DO. Oct. 2006. 6 hours.
• The Top 20 Nutritional Strategies every Health Provider Needs to Know.
Metagenics Educational Programs, Presented by Robert Rakowski, DC, CCN. Feb.
2007. 6 hours
• The Fatigue Solution. Metagenics Educational Programs, Presented by Kristi
Hughes, ND. June. 2007. 6 hours.
• First Line Therapy Certification. FLT Healthcare Provider. Metagenics Educational
Programs. Presented by Kristi Hughes, ND. Sept. 2007, Long Beach, CA.
• Beyond Metabolic Syndrome—Breakthrough Management of Disorders of Insulin
Associated with Age-Related Disease. Metagenics Educational Programs.
Presented by Jeffrey S. Bland, PhD. February 11, 2007, Los Angeles, CA. 6 hours
• The Emerging Therapeutic Target. Metagenics Educational Programs. Presented
by Jeffrey Bland, PhD.. Feburary 9, 2008, Los Angeles, CA. 6 hours
• PSI Seminars. Basic Seminar. June 25, 2008
• The Role of Clinical Nutrition in Pre and Post Traumatic Care. 2008 IAACN
Scientific Symposium. Sept. 4-7, 2008, Baltimore, MD. 20 hours.
• The Effect of Gastrointestinal Integrity on Total Body Health and Well Being. 2009
IAACN Scientific Symposium. Sept 18-21, 2009, Phoenix, AZ. 20 hours
• Nutrigenomic Therapies for Autoimmune Disease. Metagenics Educational
Programs. Presented by Thomas O’Bryan, DC. October 11, 2009, Phoenix, AZ. 6
hours.
• Linking the Signs, Dr. Stephen Stiteler, Apex Energetics. February 20-21, 2010,
Phoenix, AZ. 14 hours.
• Common Clinical Dilemmas and Misdiagnoses. IAACN 2010 Scientific Symposium,
August 18-21, 2010, Las Vegas, NV. 19 hours.
• Introduction to UNDA Numbers and Biotherapeutic Drainage. Seroyal. Presented
by Susan Godman, ND. June 4, 2011, Tempe, AZ.
• Fundamentals and Clinical Applications of IV Nutrient Therapies. Presented by
Virginia Osborne ND, RN. March 7-10, 2013. Tempe, AZ.
• Southwest Botanical Medicine Conference. April 13-14, 2013. Tempe, AZ.
• Integrative Cancer Medicine Symposium, 3rd Annual. Presented by the Healthy
Medicine Academy. April 26-29, 2013. Scottsdale, AZ.
• Suisse Neural Therapy Level I. April 2014. CME: 5 General, 2 Pharmacy
• Suisse Neural Therapy Level II. May 2014. CME: 5 General, 2 Pharmacy
• A Beginner’s Guide to Telemedicine. AzNMA Webinar. Presented by Christine
Girard ND, July 2014. CME: 1 General
• Oxidative Stress and Cancer. AzNMA Webinar. Presented by Lise Alschuler ND,
August 2014. CME: 1.5 Pharmacy
• Integrative Cancer Medicine Symposium, 4th Annual. Presented by the Healthy
Medicine Academy. November 7-10, 2014. Phoenix, AZ. CME: 24.75 General, 7
Pharmacy
• Evaluation and Management of Recurrent Pregnancy Loss. AzNMA Webinar.
Presented by Jaclyn Chasse ND. November 2014. CME: 1.5 Pharmacy
• Naturopathic Pharmaceutical Symptom Management in Integrative Oncology.
AzNMA Membership Meeting. Presented by Shauna Birdsall ND, Adam Keriesvsky
ND, Leah Sherman ND. December 2014. CME: 1 General, 1 Pharmacy